(Q48614800)

13 February 2018

title

Long-term freedom from recurrence in 2 stage IV melanoma patients following vaccination with tyrosinase peptides (English)

1 reference

13 February 2018

3

Barbara Seliger

1 reference

13 February 2018

Carmen Scheibenbogen

1

Carmen Scheibenbogen

1 reference

13 February 2018

Ulrich Keilholz

11

Ulrich Keilholz

1 reference

13 February 2018

Anne Letsch

5

Anne Letsch

1 reference

13 February 2018

Dirk Nagorsen

2

Dirk Nagorsen

1 reference

13 February 2018

Alexander Schmittel

4

Alexander Schmittel

1 reference

13 February 2018

Sandra Bauer

6

Sandra Bauer

1 reference

13 February 2018

author name string

Nicole Max

7

1 reference

13 February 2018

Michaela Bock

8

1 reference

13 February 2018

Derek Atkins

9

1 reference

13 February 2018

Eckhard Thiel

10

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

13 February 2018

International Journal of Cancer

published in

1 reference

13 February 2018

volume

99

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

page(s)

403-408

1 reference

13 February 2018

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

cites work

1 reference

Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma.

21 January 2018

1 reference

Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide

21 January 2018

1 reference

Antigen-processing machinery breakdown and tumor growth

21 January 2018

1 reference

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

21 January 2018

1 reference

Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial

21 January 2018

1 reference

Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells.

21 January 2018

1 reference

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin

21 January 2018

1 reference

Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma

21 January 2018

1 reference

Status of activation of circulating vaccine-elicited CD8+ T cells

21 January 2018

1 reference

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

21 January 2018

1 reference

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

21 January 2018

1 reference

The multiple ways to tumor tolerance

21 January 2018

1 reference

Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine

21 January 2018

1 reference

HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes

21 January 2018

1 reference

Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A

21 January 2018

1 reference

Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells

21 January 2018

1 reference

Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10328

1 reference

13 February 2018

1 reference

13 February 2018